Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Diabetes Research and Clinical Practice|November 27, 2004
An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in KoreaD M Kim, C W Ahn, J S Park, et al.
Diabetes Research and Clinical Practice|November 27, 2004
Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal womenD M Kim, S J Yoon, C W Ahn, et al.
Diabetes Research and Clinical Practice|January 7, 2000
Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathyY S Yun, H C Lee, N C Yoo, et al.
Yonsei Medical Journal|April 13, 1999
The validity of random urine specimen albumin measurement as a screening test for diabetic nephropathyC W Ahn, Y D Song, J H Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapyJ E Mok, Y M Kim, M H Jung, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 1, 1994
Reduced growth hormone response to L-dopa and pyridostigmine in obesityE J Lee, K R Kim, K M Lee, et al.
Diabetes Research and Clinical Practice|March 6, 2009
The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFGJ S Nam, J S Park, M H Cho, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 1, 1997
Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormoneS Y Nam, E J Lee, K R Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1995
Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjectsE J Lee, S Y Nam, K R Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapyJ H Nam, Y M Kim, M H Jung, et al.
Pageof 12